| Execution period | July 1, 2027 to June 30, 2033 |
|---|
BSE filing, NSE: JMFINANCIL. Summary written from the filing by ALFA Finder's alert engine.
JM Financial Ltd: key numbers
- Share price
- ₹113.23
- Market cap
- ₹10,836 Cr
- Revenue (annual)
- ₹4,091 Cr
- Net profit (annual)
- ₹1,202 Cr
- P/E (TTM)
- 10.4×Sector 21.4×
- Promoter holding
- 57.95%+0.92% QoQ
- FII holding
- 16.87%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from JM Financial Ltd
All →JM Financial Other Announcement
The company filed its quarterly shareholding pattern as mandated by Regulation 31(1)(b) for the quarter ending September 30, 2026.
JM Financial Merger & Restructuring
JM Financial Limited incorporated "JM Financial (Middle East) Limited" as a wholly-owned step-down subsidiary in the Abu Dhabi Global Market.
JM Financial Board Meeting Date
JM Financial Ltd has scheduled a board meeting on November 4, 2026, to consider and approve the unaudited standalone and consolidated financial results for Q2 FY2027.
JM Financial Employee Stock Options
Designated person Amitabh Mohanty and employee Vikas Shah acquired equity shares in JM Financial Limited. The acquisitions were conducted through the company's ESOP scheme.
- Value
- ₹0.51 Cr
JM Financial Acquisition Worth ₹162.6 Cr
JM Financial's subsidiary subscribed to a rights issue of its step-down subsidiary, JMFARC, for ₹162.59 crore, increasing its stake to 84.87%.
- Value
- ₹162.6 Cr
JM Financial Employee Stock Options
JM Financial Limited allotted 45,000 equity shares following the exercise of stock options under its ESOS scheme. This increases the company's paid-up share capital to 95.70 Crore shares.
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.